ClinicalTrials.gov
public full text
Public Domain
The Safety and Efficacy of Istaroxime for Pre-Cardiogenic Shock
This is a pilot, multinational, randomized, double-blind, placebo-controlled, 2-part safety and efficacy study. Subjects will consist of patients hospitalized for acute decompensated heart failure with persistent hypotension.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Patient Characteristics, Management and Long-Term Outcomes of Patients With Cardiogenic Shock at a Large Safety Net Hospital.#1054145
- Readily Available Urinary Sodium Analysis in Patients With Acute Decompensated Heart Failure#864438
- Treatment With the Ketone Body 3-hydroxybutyrate in Patients With Cardiogenic Shock#865411
- Cardiogenic shock: a review of contemporary approaches and ongoing challenges.#615771
- Effects of Empagliflozin on Diuresis and Renal Function in Patients With Acute Decompensated Heart Failure#1171840
Record · ID 807293
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive